NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target

Figure 7

NEIL3 was associated with sensitivity to immunotherapy and chemotherapy in lung cancer patients. Notes: (a) correlation between NEIL3 and several immune checkpoint genes; (b) expression levels of NEIL3 in immunotherapeutic responsive and nonresponsive patients; (c, d) patients with higher NEIL3 might be more sensitive to cisplatin and paclitaxel.

(a)

(b)

(c)

(d)